Brain Scientific begins trading in the OTCQB risk market

NEW YORK, NY, August 3, 2020 (GLOBE NEWSWIRE) – NEWMEDIAWIRE – Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical software and device company, announced that its non-unusual shares began trading on the OTCQB® Venture market on July 29, 2020. The OTCQB® Venture market is aimed at start-ups and progression companies in the U.S. And from abroad.

Commenting on the start of trading on the OTCQB market® Venture, Boris Goldstein, president and executive vice president, said, “On behalf of Brain Scientific, I am proud that our non-unusual stocks are now trading in OTCQB and look forward to a higher level of visibility and liquidity, as well as the expansion of Brain Scientific’s investor group.”

About Brain Scientific

Brain Scientific is a fitness care advertising company with two FDA-approved products, offering next-generation responses to the neurology market. The company’s intelligent diagnostic devices and sensors simplify management, shorten scanning time, and reduce costs, allowing physicians to make quick decisions remotely and close the hole in the development of neurological care. To learn more about our trading strategy, gadgets or investor relations, visit: www.brainscientific.com or email us at [email protected].

The OTCQB Venture market allows U.S. and foreign corporate securities to be traded at an early and progressive level through a network of OTC brokers. Over-the-market trade facilitates higher liquidity and progressive transparency. Commercial corporations are up-to-date in their reports, must meet a minimum bid value criterion and go through an annual audit and certification process of control.

Forward-looking statements

All statements contained in this press release that do not describe old facts may constitute forward-looking statements. Forward-looking statements, that involve assumptions and describe our long-term plans, methods, and expectations, are sometimes identifiable by using the words “possibly,” “should,” “should,” “would,” “would,” “could “anticipate”, “expect”, “anticipate”, “estimate”, “believe”, “pretend”, ” seek “or” project “or the negative of words or other diversifications of words or other diversifications. These forward-looking statements are not intended to expect or guarantee actual effects, performance, occasions or cases, and may not be learned as they are based on the Company’s existing projections, plans, objectives, beliefs, expectations, estimates and assumptions, and are the subject of various hazards, insecurities and other influences over which the Company has no control. The actual effects and timing of certain occasions and cases may differ materially from those described in the forward-looking statements as a result of these dangers and insecurities. Factors that may influence or contribute to the inaccuracy of forward-looking statements or cause the actual effects to differ materially from expected or desired effects may include, but are not limited to, the Company’s inability to download more financing or receive no more investors, significant duration and resources related to the progression of our products and inadequate money and the company’s resulting inability to grow its business to grow , significant government regulation of medical devices and the health sector, lack of product diversification, volatile costs for the company without cooking fabric products and the company’s inability to implement its business plans or methods. These and other points are known and described in more detail in the company’s filings with the SEC. The Company does not undertake to update such forward-looking statements.

Contact: Irina [email protected]

Leave a Comment

Your email address will not be published. Required fields are marked *